Studies in high-grade gliomas demonstrated that GLAST expression is enhanced compared to low-grade tumors, while GLT1 is decreased in glioma cells, enhancing extracellular glutamate levels [267,284]. This evidence concerns the gene SLC1A2 and central nervous system cancer.